Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study

IntroductionTotal baseline tumor size (BTS) is a prognostic factor for programmed death 1 and programmed death-ligand 1 (PD-L1) inhibitor treatments. However, the prognostic value of total BTS for patients with small-cell lung cancer (SCLC) who receive chemotherapy plus PD-L1 inhibitor remains unkno...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Anna Tanaka, Shuhei Teranishi, Yukihito Kajita, Tomofumi Hirose, Ayami Kaneko, Yu Sairenji, Hidetoshi Kawashima, Kentaro Yumoto, Toshinori Tsukahara, Kenji Miura, Nobuaki Kobayashi, Masaki Yamamoto, Ryuichi Nishihira, Makoto Kudo, Naoki Miyazawa, Masanori Nishikawa, Takeshi Kaneko
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2024-11-01
Serija:	Frontiers in Oncology
Teme:	baseline tumor size first-line therapy immune checkpoint inhibitor overall survival programmed death-ligand 1 inhibitor small-cell lung cancer
Online dostop:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1400277/full
Oznake:	Označite Brez oznak, prvi označite!